Catalyst Wire Dossier Catalyst Wire Dossier

Olokizumab

olokizumab · R-Pharm International, LLC
Drug timelines are a Plus or Pro feature.

14 regulatory and trial events tracked for Olokizumab, covering 2012-10-30 to 2026-06-30. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety of Olokizumab in Patients With Polymyalgia Rheumatica (PROMISE) [Phase 3]

See pricing